心臟假体设备市场规模、份额、成长分析（按产品类型、按材料类型、按最终用途、按地区）- 产业预测，2025 年至 2032 年

预计 2023 年全球心臟假体设备市场价值将达到 69.3 亿美元，并从 2024 年的 74.7 亿美元增长到 2032 年的 136.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.8%。

全球心臟假体市场受到老龄人口快速成长的显着影响。由于与老龄化的心臟变化，老年人口罹患心血管疾病的风险更高。这种人口结构变化导致主动脉瓣狭窄和心臟衰竭等疾病的发生率上升，促使使用人工瓣膜和起搏器的外科手术数量激增。同时，微创经导管主动脉瓣置换术(TAVR)、3D 列印个人化心臟瓣膜以及生物相容性材料等技术进步正在提高这些设备的有效性和安全性。这些技术创新不仅降低了手术风险和恢復时间，还改善了长期疗效，从而增加了整个医疗领域对人工心臟的需求，并推动了市场的持续成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

心臟假体设备市场规模（依产品类型及复合年增长率）（2025-2032）

• 市场概览
• 心臟瓣膜
  • 人工心臟瓣膜
  • 组织心臟瓣膜
  • 经导管心臟瓣膜 (TAVR)
• 起搏器
  • 植入式心律调节器
  • 体外心律调节器
• 其他的
  • 心室辅助装置（VAD）
  • 全人工心臟（TAH）

心臟假体设备市场规模（依材料类型及复合年增长率）（2025-2032 年）

• 市场概览
• 生物材料
  • 牛
  • 猪组织
• 合成材料
  • 钛
  • 聚氨酯
  • 碳
• 混合材料

心臟假体设备市场规模（依最终用途及复合年增长率） （2025-2032）

• 市场概览
• 医院
• 心臟中心诊所
• 门诊手术中心
• 其他的

心臟假体装置市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Edwards Lifesciences Corporation（USA）
• LivaNova PLC（UK）
• Biotronik（Germany）
• MicroPort Scientific Corporation（China）
• Meril Life Sciences Pvt. Ltd.（India）
• Lepu Medical Technology Co., Ltd.（China）
• CryoLife, Inc.（USA）
• AtriCure, Inc.（USA）
• Braile Biomedica（Brazil）
• Labcor Laboratorios Ltda.（Brazil）
• Lifetech Scientific Corporation（China）
• Shree Pacetronix Ltd.（India）
• TTK Healthcare Ltd.（India）
• Colibri Heart Valve LLC（USA）
• Berlin Heart GmbH（Germany）
• SynCardia Systems LLC（USA）
• Venus Medtech（Hangzhou）Inc.（China）

结论和建议

Global Cardiac Prosthetic Devices Market size was valued at USD 6.93 billion in 2023 and is poised to grow from USD 7.47 billion in 2024 to USD 13.62 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The global market for cardiac prosthetic devices is significantly influenced by the rapidly growing elderly population, which faces heightened risks of cardiovascular diseases due to age-related changes in the heart. This demographic shift is resulting in increased incidences of conditions like aortic stenosis and heart failure, leading to a surge in surgical procedures that utilize prosthetic valves and pacemakers. In parallel, technological advancements such as minimally invasive transcatheter aortic valve replacement (TAVR), 3D-printed personalized heart valves, and biocompatible materials are enhancing the efficacy and safety of these devices. These innovations not only decrease surgical risks and recovery times but also improve long-term outcomes, thereby elevating the demand for cardiac prosthetics across healthcare settings and fostering continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Prosthetic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Prosthetic Devices Market Segments Analysis

Global Cardiac Prosthetic Devices Market is segmented by Product Type, Material Type, End-Use and region. Based on Product Type, the market is segmented into Heart Valves, Pacemakers and Others. Based on Material Type, the market is segmented into Biological Materials, Synthetic Materials and Hybrid Materials. Based on End-Use, the market is segmented into Hospitals, Cardiac Centers and Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Prosthetic Devices Market

The increasing prevalence of cardiac diseases worldwide is a significant factor propelling the growth of the global cardiac prosthetic devices market. As conditions such as coronary artery disease and heart valve disorders become more common, the demand for prosthetic solutions, including heart valves and vascular grafts, escalates. This rising need not only highlights the urgency for effective treatment options but also paves the way for advancements and innovations within the market. Consequently, this trend creates substantial opportunities for manufacturers and healthcare providers to develop and deliver advanced cardiac prosthetic devices, thereby enhancing patient outcomes and market expansion.

Restraints in the Global Cardiac Prosthetic Devices Market

The Global Cardiac Prosthetic Devices market faces significant challenges due to lengthy and complex regulatory approval processes. The rigorous regulatory demands, along with the necessity for extensive clinical trials and testing, can significantly delay the market entry of new devices. This prolonged timeline not only stifles innovation but also limits patient access to the latest technological advancements. Consequently, these regulatory hurdles can impede progress in the industry, making it difficult for patients to benefit from newly developed cardiac prosthetic solutions in a timely manner.

Market Trends of the Global Cardiac Prosthetic Devices Market

The global cardiac prosthetic devices market is increasingly trending towards advancements in minimally invasive procedures, reflecting a growing preference for technologies that enhance patient outcomes. Innovative devices such as transcatheter heart valves and catheter-based repair systems are gaining traction, driven by their ability to minimize surgical trauma, reduce recovery times, and lower complication risks. As healthcare providers and patients alike prioritize efficiency and safety, the demand for these sophisticated devices is expected to surge. This shift not only aligns with evolving surgical practices but also fosters competitive growth among manufacturers, leading to ongoing technological advancements within the cardiac prosthetics segment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Cardiac Prosthetic Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves
  • Transcatheter Heart Valves (TAVR)
• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Others
  • Ventricular Assist Devices (VADs)
  • Total Artificial Hearts (TAH)

Global Cardiac Prosthetic Devices Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Biological Materials
  • Bovine Pericardium
  • Porcine Tissue
• Synthetic Materials
  • Titanium
  • Polyurethane
  • Carbon
• Hybrid Materials

Global Cardiac Prosthetic Devices Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Cardiac Centers and Clinics
• Ambulatory Surgical Centers
• Others

Global Cardiac Prosthetic Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Material Type, End-Use)
  • US
  • Canada
• Europe (Product Type, Material Type, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcor Laboratorios Ltda. (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations